We are monitoring the impact of COVID-19 on APAC Smart Inhalers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5829
Share on
Share on

Asia Pacific Smart Inhalers Market Research Report - Segmented By Product Type, By Disorder, By End-user and By Country (India, China, Japan, Australia, New Zealand, ASEAN Countries and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2020 to 2025)

Pulished: February, 2020
ID: 5829
Pages: 145

The Asia Pacific Smart Inhalers Market Size (2020 to 2025)

The size of the Smart Inhalers Market in the Asia Pacific was worth USD 14.67 million in 2020 and estimated to be growing at a CAGR of 75.23% to reach USD178.11 million by 2025. 

The growth of the APAC smart inhalers market is primarily due to an increasing elderly population, an increased prevalence of chronic obstructive pulmonary disease and asthma, and increased medical awareness.

The growth of the smart inhaler market is due to increased air pollution, and the burden on healthcare services due to the increased number of cases of COPD and asthma. Besides, more smart inhalers are being used to properly manage COPD and asthma, further driving the market growth. The rapid development of urbanization and an increase in the number of people with respiratory diseases are increasing throughout the Asia-Pacific region.

Some of the other factors that have led to an increase in the number of cases of asthma and COPD throughout the Asia-Pacific region are increased air pollution levels and increased smoking habits. An increasing number of patients with asthma and chronic obstructive pulmonary disease and technological advances in developing better smart inhalers and systems is to present growth opportunities for the market. Also, in developing regions with large populations and the potential of untapped markets is expected to provide ample opportunities for trends in the Asia-Pacific smart inhalers market. 

The dearth of skilled persons is a major challenging factor in the APAC Smart Inhalers Market. Fluctuations in the availability of raw materials used to manufacture smart inhalers are limiting the growth of the market.

This research report segmented and sub-segmented into the following categories:

  • By Product Type: Nebulizers and Inhalers
  • By Disorder: Chronic Obstructive Pulmonary Disease, Asthma and Other
  • By End-user: Patients, R&D, and Others
  • By Country: India, China, Japan, South Korea, Australia & New Zealand, ASEAN countries (Indonesia, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, and others) and Rest of APAC)

Regionally, the Asia-Pacific region is anticipated to have the fastest-growing rate due to the high investments by the government organizations and private companies in the medical industry, growth in the aging population, and emerging economies like China and India.

India and China are the two major countries contributing to the highest shares of the market. Increasing the economy steadily from the past few years is ascribed to bolster the demand of the market in these countries. Besides, growing awareness among people towards the availability of various products is also greatly influencing the demand of the smart inhalers market. Rising need to launch innovative products in favor of the end-users is extensively boosting up the growth rate of this market. Japan is next to these countries in holding dominant shares of the market with a growing number of respiratory diseases. The emergence of advanced technology and also the rising scale of research centers in the medical sector are promoting the demand of the market. Australia and the Rest of the Asia Pacific are deemed to have a steady pace during the forecast period. Rise in the prevalence to provide better healthcare infrastructure and facilities to the patients is lucrative to setup growth opportunities for the market in these countries.

The Top companies leading in the APAC Smart Inhalers Market profiled in the report are Vectura Group plc, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, Adherium Limited, Cohero Health, LLC, Propeller Health, GlaxoSmithKline plc and OPKO Health, Inc.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                                        

                                5.1.1 Introduction                                           

                                5.1.2 Nebulizers                                               

                                5.1.3 Inhalers                                    

                                                5.1.3.1 Metered Dose Inhalers (MDIs)                   

                                                5.1.3.2 Dry Powder Inhalers (DPIs)                          

                                5.1.4 Y-o-Y Growth Analysis, By Product                                               

                                5.1.5 Market Attractiveness Analysis, By Product                                             

                                5.1.6 Market Share Analysis, By Product                                               

                5.2 Disorder                                                       

                                5.2.1 Introduction                                           

                                5.2.2 Chronic Obstructive Pulmonary Disease (COPD)                                     

                                5.2.3 Asthma                                     

                                5.2.4 Others                                      

                                5.2.5 Y-o-Y Growth Analysis, By Disorder                                              

                                5.2.6 Market Attractiveness Analysis, By Disorder                                            

                                5.2.7 Market Share Analysis, By Disorder                                              

                5.3 End-user                                                      

                                5.3.1 Introduction                                           

                                5.3.2 Patients                                    

                                5.3.3 R&D                                           

                                5.3.4 Others                                      

                                5.3.5 Y-o-Y Growth Analysis, By End-user                                             

                                5.3.6 Market Attractiveness Analysis, By End-user                                           

                                5.3.7 Market Share Analysis, By End-user                                             

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Disorder                         

                                                6.1.3.4 By End-user                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Disorder                         

                                                6.1.4.4 By End-user                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Disorder                         

                                                6.1.5.4 By End-user                        

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Vectura Group plc                                                   

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Teva Pharmaceutical Industries Ltd.,                                                               

                8.3 GlaxoSmithKline plc                                                

                8.4 Boehringer Ingelheim GmbH                                                              

                8.5 AstraZeneca plc,                                                       

                8.6 Adherium Limited                                                    

                8.7 Cohero Health, LLC,                                                                

                8.8 Propeller Health                                                       

                8.9 GlaxoSmithKline plc                                                

                8.10 OPKO Health, Inc.                                                  

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Asia pacifc and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by product type, along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1.  
  2. Asia Pacific Smart Inhalers Market, By Product type , From 2020 to 2025 (USD Million)
  3. Asia Pacific Nebulizers Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia Pacific Inhalers  Market, By Region, From 2020 to 2025 (USD Million)
  5. Asia Pacific Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  6. Asia Pacific Chronic Obstructive Pulmonary Disease Market, By Region, From 2020 to 2025 (USD Million)
  7. Asia Pacific Asthma Market, By Region, From 2020 to 2025 (USD Million)
  8. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Million)
  9. Asia Pacific Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  10. Asia Pacific Patients Market, By Region, From 2020 to 2025 (USD Million)
  11. Asia Pacific R&D Market, By Region, From 2020 to 2025 (USD Million)
  12. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Million)
  13. Japan Smart Inhalers Market, By Product type , From 2020 to 2025 (USD Million)
  14. Japan Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  15. Japan Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  16. China Smart Inhalers Market, By Product type , From 2020 to 2025 (USD Million)
  17. China Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  18. China Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  19. India Smart Inhalers Market, By Product type , From 2020 to 2025 (USD Million)
  20. India Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  21. India Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  22. Australia Smart Inhalers Market, By Product type , From 2020 to 2025 (USD Million)
  23. Australia Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  24. Australia Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  25. South Korea Smart Inhalers Market, By Product Type , From 2020 to 2025 (USD Million)
  26. South Korea Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  27. South Korea Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample